MedPath

Ultrasound-guided Intermediate Cervical Plexus Block

Not Applicable
Completed
Conditions
Internal Carotid Artery Stenosis
Interventions
Other: cervical plexus block
Other: facial nerve block
Other: perivascular block
Registration Number
NCT02794974
Lead Sponsor
Helios Research Center
Brief Summary

The investigators test with the present study design, whether an ultrasound-guided blockade of the cervical plexus in combination with an additional application of local anesthetic to the superficial cervical ansa (facial nerve: cervical branch) leads to an improved quality of anesthesia.

Detailed Description

The innervation of the neck area is complex and includes cranial nerve (innervation of the vessel wall (IX,X) and of the neck muscles (VII,XI)), as well as the cervical plexus and brachial plexus. This is a major cause of insufficient anesthesia quality during carotid endarterectomies.

The investigators test with the present prospective study design, whether an ultrasound-guided blockade of the cervical plexus in combination with an additional application of local anesthetic to the superficial cervical ansa (facial nerve: cervical branch) leads to an improved quality of anesthesia.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
29
Inclusion Criteria
  • internal carotid stenosis: open surgical revascularization
  • age over 18 years
  • written informed consent
Exclusion Criteria
  • allergy (local anesthetics)
  • pregnancy
  • participation in other studies
  • drug addiction
  • non-cooperative patients

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
with perivascular blockfacial nerve block1. ultrasound-guided intermediate cervical plexus block (20ml ropivacaine 0.75%) 2. facial nerve block (cervical branch) (5ml prilocaine 1%) 3. perivascular block (5ml prilocaine 1%)
without perivascular blockcervical plexus block1. ultrasound-guided intermediate cervical plexus block (20ml ropivacaine 0.75%) 2. facial nerve block (cervical branch) (5ml prilocaine 1%)
with perivascular blockcervical plexus block1. ultrasound-guided intermediate cervical plexus block (20ml ropivacaine 0.75%) 2. facial nerve block (cervical branch) (5ml prilocaine 1%) 3. perivascular block (5ml prilocaine 1%)
with perivascular blockperivascular block1. ultrasound-guided intermediate cervical plexus block (20ml ropivacaine 0.75%) 2. facial nerve block (cervical branch) (5ml prilocaine 1%) 3. perivascular block (5ml prilocaine 1%)
without perivascular blockfacial nerve block1. ultrasound-guided intermediate cervical plexus block (20ml ropivacaine 0.75%) 2. facial nerve block (cervical branch) (5ml prilocaine 1%)
Primary Outcome Measures
NameTimeMethod
Local Anesthetic Supplementation (Frequency)intraoperatively

number of participants who need supplementation of prilocaine 1% by the surgeon (%)

Local Anesthetic Supplementation (Volume)intraoperatively

volume of prilocaine 1% supplemented by the surgeon (ml)

Secondary Outcome Measures
NameTimeMethod
Coughintraoperatively

number of participants who experienced side effects: cough

Dysphagiaintraoperatively

number of participants who experienced side effects: dysphagia

Hoarsenessintraoperatively

number of participants who experienced side effects: hoarseness

Trial Locations

Locations (1)

Helios Medical Center Schwerin, Department of Anaesthesiology and Intensive Care

🇩🇪

Schwerin, Mecklenburg-Vorpommern, Germany

© Copyright 2025. All Rights Reserved by MedPath